Clorox CO /DE/ Form 4 insider transactions

EVP and Chief Legal Officer of Clorox, Angela C. Hilt, reports acquiring 5,221 shares of common stock at $164.69 per share on September 17, 2024.

EVP and Chief People Officer of Clorox, Kirsten Marriner, reports acquiring 5,221 shares of common stock at $164.69 per share.

EVP Stacey Grier acquired 2,550 shares of Clorox common stock at a price of $164.69 per share on September 17, 2024.

Eric H. Reynolds, EVP and Chief Operating Officer of Clorox, acquired 7,286 shares of common stock at a price of $164.69 per share on September 17, 2024.

EVP and CFO of Clorox, Kevin B. Jacobsen, reports acquiring 6,800 shares of common stock at $164.69 per share.

Clorox CEO Linda Rendle acquired 23,692 shares of common stock at $164.69 per share on September 17, 2024, and now beneficially owns 103,471 shares.

EVP and Chief Operating Officer of Clorox, Eric H. Reynolds, reports disposition of shares to cover tax obligations related to vesting of restricted stock.

Clorox CEO Linda Rendle reports the withholding of 404 common stock shares to cover tax obligations related to vesting restricted stock on September 13, 2024.

Laurene E. Peck, VP CAO & Corp Controller at Clorox, reports the withholding of shares to cover tax obligations and dividend reinvestment.

EVP and Chief People Officer of Clorox, Kirsten Marriner, reports a transaction involving common stock to cover tax obligations related to vesting restricted stock.

EVP and CFO of Clorox, Kevin B. Jacobsen, reports the withholding of shares to cover tax obligations related to vesting restricted stock.

EVP and Chief Legal Officer of Clorox, Angela C. Hilt, reports a transaction involving common stock due to tax obligations and dividend reinvestment.

Stacey Grier, Executive Chief of Staff at Clorox, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock.

EVP Chris T. Hyder reports a transaction involving Clorox Co. common stock related to tax obligations from vesting restricted stock.

EVP and Chief Legal Officer of Clorox, Angela C. Hilt, sold 1,733 shares of common stock at a price of $165.5177 per share on September 6, 2024, under a pre-planned trading program.

EVP Nina Barton reports acquisition of Clorox restricted stock units.

Chris T. Hyder, Group President Health & Hygiene at Clorox, acquired 2,981 shares of Clorox common stock at a price of $134.15 per share on July 15, 2024.

Director Kathryn Tesija reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of director's fees.

Director Amy Banse reports acquiring Clorox shares in lieu of director's fees and deferred stock units through dividend reinvestment.

Director Christopher J. Williams acquired Clorox shares and deferred stock units in lieu of director's fees, according to a recent SEC filing.

Director Russell J. Weiner reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of director's fees.

Stephanie Plaines, a director of Clorox, reported the acquisition of deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Paul Gray Parker increased his holdings in Clorox through stock acquisition and dividend reinvestment in deferred stock units.

Director Spencer C. Fleischer reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Russell J. Weiner reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Kathryn Tesija reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of quarterly director's fees.

Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Director Stephanie Plaines reports acquisition of deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Director Spencer C. Fleischer reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.